Author: Paul Govern
Study explores issues faced by early career research faculty
Jun. 28, 2018—In an electronic survey of early career research-track faculty at Vanderbilt University Medical Center, respondents confidentially reported their recent experiences with extra-professional caregiving, including care for sick or injured children, parents, spouses or partners.
Records point to drug-drug interaction
May. 7, 2018—Patients who take a cholesterol-lowering statin drug while taking the antibiotic daptomycin have increased risk of developing muscle weakness or a more severe form of muscle damage.
Speakers discuss use of evidence in state health policymaking
Apr. 19, 2018—“State Health Policy: Does Evidence Really Make a Difference” was the title of the spring Research into Policy and Practice Lecture, April 11 in Light Hall. The semi-annual lecture is sponsored by the Department of Health Policy.
New labeling system speeds clinical lab turnaround times
Apr. 19, 2018—Much of everyday clinical decision-making is informed by lab tests performed rapidly on automated instrumentation — basic metabolic panels, complete blood counts, all the lab orders for which clinicians expect quick results.
VUMC drug repurposing initiative gaining momentum
Apr. 19, 2018—Drug repurposing involves establishing an additional approved indication for a drug already at market.
VUMC health records now available on iPhone Health app
Apr. 2, 2018—Vanderbilt University Medical Center is among an initial 39 health systems supporting a new health records feature on the iPhone.
Study finds broken circadian clock in human tumors
Mar. 29, 2018—Human tumors appear to have a broken circadian clock, researchers at Vanderbilt University Medical Center report in the journal PeerJ.
Grant bolsters study of potential new therapy for C. diff infection
Mar. 22, 2018—According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis.
Study reveals safety signal from genes that mimic drugs
Mar. 1, 2018—Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal Drug Safety by researchers at Vanderbilt University Medical Center.
Chren recognized by dermatology academy
Feb. 15, 2018—Mary-Margaret “Meg” Chren, MD, chair of the Department of Dermatology, is the recipient of the 2018 Clarence S. Livingood, MD, Memorial Award and Lectureship from the American Academy of Dermatology (AAD).
AIDS-defining events increase mortality risk: study
Feb. 8, 2018—When they occur among people living with HIV, certain cancers and opportunistic infections are considered by health authorities as AIDS-defining events, or ADEs.
Study evaluates community-based health efforts
Feb. 1, 2018—A new study from researchers at Vanderbilt and Harvard universities, published this week in the journal Health Affairs, uses federal health survey data to evaluate community-based efforts to address smoking, obesity and other health conditions such as type 2 diabetes and hypertension.